Cargando…
Immune Checkpoint Inhibitor-Induced Colitis Presenting As Lymphocytic Colitis
Checkpoint inhibitors (CPIs) are a new class of drugs that have changed the treatment and prognosis of several malignancies, even in their advanced stages. These drugs have increased patient survival rates. CPIs stimulate the immune system and include cytotoxic T-lymphocyte antigen-4 inhibitors (ipi...
Autores principales: | Khan, Jaffar, Katona, Terrence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523195/ https://www.ncbi.nlm.nih.gov/pubmed/34692300 http://dx.doi.org/10.7759/cureus.18085 |
Ejemplares similares
-
Immune Checkpoint Inhibitor-Induced Acute Pancreatitis and Colitis
por: Pagan, Andrea, et al.
Publicado: (2020) -
Immune Checkpoint Inhibitor-Induced Lymphocytic Esophagitis
por: Amin, Shefali, et al.
Publicado: (2023) -
Focal Active Colitis Presented With Chronic Diarrhea
por: Mandzhieva, Bayarmaa, et al.
Publicado: (2020) -
Ischemic Colitis in Buerger’s Disease: Case Presentation and Review
por: Naqvi, Haider A, et al.
Publicado: (2020) -
An Unusual Presentation of Clostridioides Difficile Colitis in a Patient on Opioids
por: Ajibola, Oluwafemi A, et al.
Publicado: (2022)